-
Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine Scientific Interest Group. Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-31 Jessica Day,Hani Kushlaf,Stacey Tarvin,Lorenzo Cavagna,Veronica Codullo,Samuel Katsuyuki Shinjo,Xia Lyu,Johannes Knitza,Raouf Hajji,Peter R Blier,Chih Wei Tseng,Simone Appenzeller,Lisa G Rider,Lisa Christopher-Stine,Latika Gupta,
-
The Elusive Truth of Cannabinoids for Rheumatic Pain Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-09 Hance Clarke, Sarah Miles, Miki Peer, Mary-Ann Fitzcharles
Purpose of Review Medical cannabis (MC) has entered mainstream medicine by a unique route. Regulatory acceptance as a medical product in many jurisdictions has bypassed the traditional evidence-based pathway required for therapies. Easier access to MC, especially related to recreational legalization of cannabis, has led to widespread use by patients for symptom relief of a variety of medical conditions
-
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-09 Sharmila Khot, George Tackley, Ernest Choy
-
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-08 Simone Battista, Benedetto Giardulli, Cristiana Sieiro Santos, Or Aharonov, Darshan Puttaswamy, Anne – Marie Russell, Latika Gupta
-
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-05 Konstantinos Parperis, Argyris Constantinou
Purpose of the Review This review provides an overview of medical conditions and risk factors associated with CPPD. Recent Findings Recent studies have indicated that CPPD patients may have a higher risk for systemic conditions such as cardiovascular diseases. Summary Calcium pyrophosphate deposition disease (CPPD) is a common crystal arthropathy that primarily affects older adults, and, in most cases
-
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-02 Katarina J. Bade, Kevin T. Mueller, Jeffrey A. Sparks
Purpose of Review The goal of this review paper is to summarize the main research and findings regarding air pollution and its association with the risk and progression of rheumatoid arthritis (RA). Recent Findings The most studied components of air pollution included particulate matter of ≤ 2.5 microns in diameter (PM2.5), PM10, carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOx), sulfur
-
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-08-01 Silvia Sirotti, Anna Scanu, Tristan Pascart, Tom Niessink, Paola Maroni, Giovanni Lombardi, Georgios Filippou
-
Updates in diagnosis and treatment of pediatric antiphospholipid syndrome Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-07-24 Lucia M. Campos, Paula S. Marra, Clara R. Doria, Sebastian D. Cordoba, Clovis A. Silva
Purpose of Review This review offers an overview of the most important recent articles on pediatric APS. Recent Findings Non-thrombotic extra criteria manifestations were prevalent in pediatric APS. Pregnancy morbidity has been described as the first manifestation of APS at youth age, impairing gestational outcomes. The 2023 APS criteria were developed for adult APS patients, and there is still a lack
-
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-06-24 Jens Rathmann, Aladdin J. Mohammad
-
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-06-20 Silvia Scriffignano, Fabio Massimo Perrotta, Ennio Lubrano
-
Gaining Insight into Updated MR Imaging for Quantitative Assessment of Cartilage Injury in Knee Osteoarthritis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-05-29 Peng Luo, Li Lu, Run Xu, Lei Jiang, Guanwu Li
-
Review: The Role of Dual-Energy Computed Tomography in Detecting Monosodium Urate Deposits in Vascular Tissues Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-05-13 Julia Held, David Haschka, Pietro G. Lacaita, Gudrun M. Feuchtner, Werner Klotz, Hannes Stofferin, Christina Duftner, Günter Weiss, Andrea S. Klauser
-
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-05-06 Faten Aqeel, Duvuru Geetha
-
Current perspective on infections and mitigation strategies in primary systemic vasculitis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-04-26 Manuel Carpio Tumba, Raisa Lomanto Silva, Ana B. Arevalo, Sebastian E. Sattui
-
Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-04-23 Quentin Moyon, Alexis Mathian, Matthias Papo, Alain Combes, Zahir Amoura, Marc Pineton de Chambrun
-
Decoding the Intricacies of Statin-Associated Muscle Symptoms Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-04-05 Tara Fallah Rastegar, Imtiaz Ahmed Khan, Lisa Christopher-Stine
-
AA Amyloidosis: A Contemporary View Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-04-03 Safak Mirioglu, Omer Uludag, Ozge Hurdogan, Gizem Kumru, Ilay Berke, Stavros A. Doumas, Eleni Frangou, Ahmet Gul
-
From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-03-21 A. L. Ribeiro, L. Eder
-
JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-03-16 Siba P. Raychaudhuri, Ruchi J. Shah, Sneha Banerjee, Smriti K. Raychaudhuri
-
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-03-11 Sonia Butler, Dean Sculley, Derek Santos, Xavier Girones, Davinder Singh-Grewal, Andrea Coda
Purpose of Review This critical review begins by presenting the history of Juvenile Idiopathic Arthritis (JIA) management. To move the conversation forward in addressing the current shortcomings that exist in the clinical management of children living with JIA, we argue that to date, the advancement of successful treatments for JIA has been historically slow. Factors implicated in this situation include
-
Osteoarthritis as an Enhanceropathy: Gene Regulation in Complex Musculoskeletal Disease Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-03-02 Jack B. Roberts, Sarah J. Rice
-
Precision Medicine in Rheumatology: The Promise of Ultrasound-Guided Synovial Biopsy, Barriers to Its Implementation in the United States, and Proposed Solutions Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-20 Diane Lewis Horowitz, Arthur M. Mandelin, Darren Tabechian, Ami Ben-Artzi
-
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-19 Thomas Foret, Virginie Dufrost, Jeremy Lagrange, Patricia Costa, Guillaume Mourey, Thomas Lecompte, Nadine Magy-Bertrand, Veronique Regnault, Stéphane Zuily, Denis Wahl
-
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-19 Anand Kumthekar, Nirali Sanghavi, Anuya Natu, Abhijeet Danve
-
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-19 Wang-Chun Ho, Chung-Chih Chang, Wen-Tien Wu, Ru-Ping Lee, Ting-Kuo Yao, Cheng-Huan Peng, Kuang-Ting Yeh
Purpose of Review The purpose of this literature review was to determine if medications used to treat osteoporosis are also effective for treating osteoarthritis (OA). Recent Findings A total of 40 relevant articles were identified. Studies were categorized into those (1) discussing estrogen and selective estrogen receptor modulators (SERMs), (2) bisphosphonates, (3) parathyroid hormone (PTH) analogs
-
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-10 Maureen Dubreuil
-
Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings) Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-09 Haseeb Chaudhary, Mohamad Bittar, Ansaam Daoud, Marina Magrey
Purpose of Review Limited data is available for tapering or discontinuation of biologic therapy in patients with axSpA who are in disease remission. The current review concentrates on published studies regarding dose tapering or withdrawal of biologics in axSpA. Recent Findings Recent evidence in light of randomized controlled trials suggests that tapering of b-DMARDs is a feasible strategy to maintain
-
Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-07 Archita Srinath, Akihiro Nakamura, Nigil Haroon
-
Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-02-01 Brenda J. Seymour, Brendan E. Allen, Kristine A. Kuhn
-
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-01-25 John A. Sturgeon, Caroline Zubieta, Chelsea M. Kaplan, Jennifer Pierce, Anne Arewasikporn, P. Maxwell Slepian, Afton L. Hassett, Zina Trost
-
Understanding Spondyloarthritis Pathogenesis: The Promise of Single-Cell Profiling Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-01-16 Joerg Ermann, Micah Lefton, Kevin Wei, Maria Gutierrez-Arcelus
-
Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings) Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-01-12 Joerg Ermann, Atul Deodhar, Muhammad Asim Khan, Michael H. Weisman, John D. Reveille
-
Erosive Hand Osteoarthritis: Recent Advances and Future Treatments Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2024-01-12 Marta B. Bean, Marta Favero, Roberta Ramonda, Carla R. Scanzello
-
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-29 Anna Helena Jonsson
-
Pipeline Therapies for Gout Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-22 Kevin Yip, Genna Braverman, Linda Yue, Theodore Fields
-
Temperature-Mediated Neural Interventions in Knee Osteoarthritis: a Review of Cryoneurolysis and Cooled Radiofrequency Ablation with Ultrasound Guidance Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-21 Christopher M. Tidwell, Paul J. DeMarco
-
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-16 Fatima K. Alduraibi, Jasvinder A. Singh
-
Calcinosis in Juvenile Dermatomyositis—Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-07 Jucier Gonçalves Júnior, Samuel Katsuyuki Shinjo
-
Role of IFN-α in Rheumatoid Arthritis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-12-05 Chung M. A. Lin, John D. Isaacs, Faye A. H. Cooles
-
Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-28 Matthew Sayer, Gavin B. Chapman, Matthew Thomas, Neeraj Dhaun
-
Multimorbidity in Rheumatoid Arthritis: Literature Review and Future Directions Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-23 Jonathan Katz, Christie M. Bartels
-
Disease and Treatment-Specific Complications of Behçet Syndrome Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-23 Sinem Nihal Esatoglu, Yesim Ozguler, Gulen Hatemi
Purpose of Review We aimed to highlight disease-related and treatment-related complications of Behçet syndrome (BS) based on previous and recent studies and our own experience. Recent Findings The Behçet’s Disease Overall Damage Index is a newly developed instrument to assess damage in BS. Validation studies showed that damage is already present in some patients at diagnosis and continues to progress
-
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-16 Shintaro Yamamoto, Akira Yoshida, Takahisa Gono, Masataka Kuwana
-
Digital Approaches for Myositis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-14 Johannes Knitza, Sebastian Kuhn, Latika Gupta
Purpose of Review This article serves as a comprehensive review, focusing on digital approaches utilized in the diagnosis, monitoring, and treatment of patients with idiopathic inflammatory myopathies (IIM). The authors critically assess the literature published in the last three years, evaluating the advancements and progress achieved in this specific domain. Recent Findings Remarkable strides have
-
HLA-B*27 and Ankylosing Spondylitis: 50 Years of Insights and Discoveries Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-11-11 Muhammad A. Khan
-
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-09-30 Carly Conran, Jason Kolfenbach, Kristine Kuhn, Christopher Striebich, Larry Moreland
-
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-09-28 Eva Vermeer, Renske C. F. Hebing, Maartje M. van de Meeberg, Marry Lin, Tim G. J. de Meij, Eduard A. Struys, Gerrit Jansen, Michael T. Nurmohamed, Maja Bulatović Ćalasan, Robert de Jonge
-
Possible Role of Dysbiosis of the Gut Microbiome in SLE Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-09-22 F. Naz Cemre Kalayci, Seza Ozen
-
The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-09-01 Syed Obaidur Rahman, Frédérique Bariguian, Ali Mobasheri
-
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-08-19 Rathnam Venkat, Zachary S. Wallace, Jeffrey A. Sparks
-
Treat-to-Target in Pediatric Rheumatic Diseases Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-08-16 Silvia Rosina, Ana Isabel Rebollo-Giménez, Alessandro Consolaro, Angelo Ravelli
-
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-08-10 Liubov Arbeeva, Mary C. Minnig, Katherine A. Yates, Amanda E. Nelson
Purpose of Review Osteoarthritis (OA) is a complex heterogeneous disease with no effective treatments. Artificial intelligence (AI) and its subfield machine learning (ML) can be applied to data from different sources to (1) assist clinicians and patients in decision making, based on machine-learned evidence, and (2) improve our understanding of pathophysiology and mechanisms underlying OA, providing
-
Emerging Concepts in Precision Medicine in Axial Spondyloarthritis Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-07-28 Hugues Allard-Chamard, Quan Li, Proton Rahman
-
Systemic Lupus Erythematosus and COVID-19 Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-07-21 Maria Pappa, Alexandros Panagiotopoulos, Konstantinos Thomas, Antonis Fanouriakis
-
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-07-15 Aggelos Banos, George Bertsias
-
Neuroimmune Mechanisms Underlying Post-acute Sequelae of SARS-CoV-2 (PASC) Pain, Predictions from a Ligand-Receptor Interactome Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-06-10 Joseph B. Lesnak, Khadijah Mazhar, Theodore J. Price
-
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-06-01 Prateek C. Gandiga, Daniela Ghetie, Elizabeth Anderson, Rohit Aggrawal
Purpose of Review Idiopathic inflammatory myopathies (IIM) are a complex family of autoimmune systemic disorders which often affect muscle and/or skin. IIM cause significant morbidity and mortality, but optimal treatment is uncertain. This review provides a practical guide for using intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) in the management of IIM, including dermatomyositis
-
An Update on the Diagnosis and Management of Calcium Crystal Disease Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-05-30 Rachael Flood, John Stack, Geraldine McCarthy
Purpose of Review This article aims to review the challenges to diagnosis and management of calcium crystal deposition diseases and evaluate the literature published over the past 3 years. Recent Findings The awaited development of classification criteria is an essential step in the progression of calcium crystal deposition disease clinical research. There have been recent improvements in the accuracy
-
Has the COVID 19 Pandemic Impacted the Management of Chronic Musculoskeletal Pain? Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-05-03 Mahdokht Parsirad, Samon Oomen-Lochtefeld, Brigette Suerig, Chenchen Wang
Purpose of Review The COVID-19 pandemic has affected the management of chronic musculoskeletal pain; however, the extent of its impact has not been established. We conducted a comprehensive review of the pandemic’s impact on clinical outcomes and healthcare accessibility for osteoarthritis (OA), rheumatoid arthritis (RA), fibromyalgia (FM), lower back pain (LBP), and other musculoskeletal disorders
-
Syndesmophyte Growth in Ankylosing Spondylitis: from Laboratory to Bedside Curr. Rheumatol. Rep. (IF 5.7) Pub Date : 2023-05-01 Michael M. Ward, Sovira Tan